Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation
- PMID: 15298733
- PMCID: PMC11159109
- DOI: 10.1111/j.1349-7006.2004.tb03330.x
Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation
Abstract
An anthelminthic, pyrvinium pamoate (PP), 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, has been found to be extremely toxic to PANC-1 cells in glucose-free medium, but not to be toxic to the same cells cultured in ordinary medium, Dulbecco's modified Eagle's medium (DMEM). It showed the same preferential toxicity for various cancer cell lines during glucose starvation. When 0.1 microg/ml PP was added to the medium, spheroid growth of human colon cancer cell line WiDr was strongly inhibited to a diameter of 750 microm, and this finding is consistent with the concept of anti-austerity. PP was also found to exert antitumor activity against human pancreatic cancer cell line PANC-1 in nude mice and SCID mice when it was administered subcutaneously or orally. Regarding the mechanism of PP action, inhibition of Akt phosphorylation, which has been found to be essential for the austerity mechanism, was observed in vitro and in vivo. These findings indicate that PP may be useful for anticancer therapy and that anti-austerity therapy could be a novel strategy for anticancer therapy.
Similar articles
-
Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy.PLoS One. 2008;3(12):e3951. doi: 10.1371/journal.pone.0003951. Epub 2008 Dec 16. PLoS One. 2008. PMID: 19079611 Free PMC article.
-
Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.Acta Biochim Biophys Sin (Shanghai). 2017 Oct 1;49(10):890-898. doi: 10.1093/abbs/gmx089. Acta Biochim Biophys Sin (Shanghai). 2017. PMID: 28981601
-
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.PLoS One. 2013 Aug 27;8(8):e71508. doi: 10.1371/journal.pone.0071508. eCollection 2013. PLoS One. 2013. PMID: 24013655 Free PMC article.
-
The novel role of pyrvinium in cancer therapy.J Cell Physiol. 2018 Apr;233(4):2871-2881. doi: 10.1002/jcp.26006. Epub 2017 Jun 20. J Cell Physiol. 2018. PMID: 28500633 Review.
-
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug.Biomedicines. 2022 Dec 14;10(12):3249. doi: 10.3390/biomedicines10123249. Biomedicines. 2022. PMID: 36552005 Free PMC article. Review.
Cited by
-
Pyrvinium targets autophagy addiction to promote cancer cell death.Cell Death Dis. 2013 May 2;4(5):e614. doi: 10.1038/cddis.2013.142. Cell Death Dis. 2013. PMID: 23640456 Free PMC article.
-
Anthelmintics for drug repurposing: Opportunities and challenges.Saudi Pharm J. 2021 May;29(5):434-445. doi: 10.1016/j.jsps.2021.04.004. Epub 2021 Apr 16. Saudi Pharm J. 2021. PMID: 34135669 Free PMC article. Review.
-
Dual drug targeting to kill colon cancers.Cancer Med. 2022 Jul;11(13):2612-2626. doi: 10.1002/cam4.4641. Epub 2022 Mar 17. Cancer Med. 2022. PMID: 35301819 Free PMC article.
-
In vitro 3D phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease.J Mol Cell Biol. 2020 Aug 1;12(8):644-653. doi: 10.1093/jmcb/mjz029. J Mol Cell Biol. 2020. PMID: 31065693 Free PMC article.
-
Pyrvinium Pamoate Use in a B cell Acute Lymphoblastic Leukemia Model of the Bone Tumor Microenvironment.Pharm Res. 2020 Jan 27;37(3):43. doi: 10.1007/s11095-020-2767-4. Pharm Res. 2020. PMID: 31989336 Free PMC article.
References
-
- Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9: 138–41. - PubMed
-
- Weinberg RA. The molecular basis of carcinogenesis: understanding the cell cycle clock. Cytokines Mol Ther 1996; 2: 105–10. - PubMed
-
- Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–6. - PubMed
-
- Folkman J. Looking for a good endothelial address. Cancer Cell 2002; 1: 113–5. - PubMed
-
- Schirner M, Hoffmann J, Menrad A, Schneider MR. Antiangiogenic chemo‐therapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res 1998; 4: 1331–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous